Holen Sie sich die Stockscreener-App
2.29
2.75%
-0.07
Schlusskurs vom Vortag:
$2.36
Offen:
$2.38
24-Stunden-Volumen:
778.46K
Relative Volume:
0.06
Marktkapitalisierung:
$309.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-35.47M
KGV:
-4.0175
EPS:
-0.57
Netto-Cashflow:
$-124.27M
1W Leistung:
-8.20%
1M Leistung:
-29.60%
6M Leistung:
+122.82%
1J Leistung:
+5.28%
1-Tages-Spanne:
$2.25
$2.38
1-Wochen-Bereich:
$2.23
$2.51
52-Wochen-Spanne:
$0.4603
$7.13
Prokidney Corp Stock (PROK) Company Profile
Firmenname
Prokidney Corp
Sektor
Branche
Telefon
336-999-7028
Adresse
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Vergleichen Sie PROK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
2.295 | 310.49M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.40 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.99 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
566.90 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
734.86 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
320.66 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-30 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-09-30 | Eingeleitet | JP Morgan | Neutral |
| 2024-09-10 | Eingeleitet | Guggenheim | Buy |
| 2024-03-07 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-07-25 | Eingeleitet | BTIG Research | Buy |
| 2022-12-21 | Eingeleitet | Jefferies | Buy |
| 2022-11-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-18 | Eingeleitet | UBS | Buy |
| 2022-10-14 | Eingeleitet | Citigroup | Buy |
| 2022-09-23 | Eingeleitet | BofA Securities | Buy |
| 2022-09-02 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Prokidney Corp Aktie (PROK) Neueste Nachrichten
ProKidney at Citi’s Biopharma Back to School Conference: CKD Therapy Progress - Investing.com
ProKidney Corp. shares rise 1.96% intraday after presenting at Citi's Biopharma back-to-school Summit. - AInvest
ProKidney Corp: Pioneering CKD Innovation in Emerging Markets - AInvest
Using data filters to optimize entry into ProKidney Corp.Weekly Gains Report & Capital Efficient Trade Techniques - Newser
Using RSI to spot recovery in ProKidney Corp.2025 Price Targets & Daily Market Momentum Tracking - Newser
Key metrics from ProKidney Corp.’s quarterly data2025 Support & Resistance & Risk Controlled Swing Alerts - Newser
How moving averages guide ProKidney Corp. trading2025 Institutional Moves & Consistent Profit Trade Alerts - Newser
Will ProKidney Corp. price bounce be sustainableMarket Sentiment Summary & Technical Entry and Exit Tips - Newser
Will ProKidney Corp. rebound enough to break even2025 Momentum Check & Real-Time Market Trend Scan - Newser
What moving averages say about ProKidney Corp.Portfolio Risk Summary & Pattern Based Trade Signal System - Newser
Real time breakdown of ProKidney Corp. stock performance2025 Price Momentum & Reliable Volume Spike Trade Alerts - Newser
Combining machine learning predictions for ProKidney Corp.IPO Watch & Safe Capital Growth Trade Ideas - Newser
Geopolitics Watch: Should value investors consider ProKidney Corp.Market Volume Report & Safe Capital Growth Stock Tips - khodrobank.com
ProKidney Corp. stock chart pattern explainedJuly 2025 Outlook & Scalable Portfolio Growth Methods - Newser
Will ProKidney Corp. bounce back from current support2025 Volatility Report & Weekly Top Gainers Trade List - Newser
Will ProKidney Corp. stock recover after recent dropTrade Volume Report & Real-Time Volume Trigger Notifications - Newser
ProKidney Corp. stock volume spike explained2025 Price Action Summary & Safe Swing Trade Setup Alerts - Newser
Can ProKidney Corp. reach resistance levels soonJuly 2025 Highlights & Low Risk Profit Maximizing Plans - khodrobank.com
Candlestick signals on ProKidney Corp. stock todayQuarterly Trade Summary & Long-Term Capital Growth Strategies - Newser
What is the PEG ratio of ProKidney Corp.July 2025 Opening Moves & Safe Entry Trade Reports - khodrobank.com
Multi factor analysis applied to ProKidney Corp.Weekly Investment Report & Growth Focused Stock Reports - Newser
Will ProKidney Corp. benefit from green energy policiesMarket Risk Analysis & Fast Exit and Entry Trade Guides - khodrobank.com
What analysts say about ProKidney Corp. stock2025 Technical Overview & Low Risk Profit Maximizing Plans - khodrobank.com
Will ProKidney Corp. stock recover after earningsJuly 2025 Closing Moves & Technical Buy Zone Confirmations - khodrobank.com
What are ProKidney Corp.’s recent SEC filings showingEarnings Performance Report & Capital Efficiency Focused Strategies - khodrobank.com
Is ProKidney Corp. a good ESG investmentWeekly Profit Recap & Fast Moving Trade Plans - خودرو بانک
ProKidney Corp. Enters Reversal Setup in Weekly Charts getLinesFromResByArray error: size == 0 - thegnnews.com
Price action breakdown for ProKidney Corp.July 2025 Patterns & Technical Entry and Exit Alerts - Newser
Is ProKidney Corp. meeting your algorithmic filter criteriaBuy Signal & Momentum Based Trading Ideas - Newser
ProKidney (PROK.O) Dives 5.6%: A Technical and Order-Flow Deep Dive - AInvest
Has ProKidney Corp. found a price floorJuly 2025 Drop Watch & Accurate Buy Signal Alerts - Newser
Volume spikes in ProKidney Corp. stock – what they meanPortfolio Value Summary & Weekly Market Pulse Updates - Newser
Analyzing drawdowns of ProKidney Corp. with statistical toolsJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Does ProKidney Corp. qualify in momentum factor screeningWeekly Loss Report & Reliable Trade Execution Plans - Newser
Using R and stats models for ProKidney Corp. forecastingQuarterly Earnings Summary & Reliable Intraday Trade Alerts - Newser
ProKidney Corp. Added to Custom Quant Screener Today getLinesFromResByArray error: size == 0 - 더경남뉴스
Regression analysis insights on ProKidney Corp. performance2025 Biggest Moves & Weekly Watchlist for Hot Stocks - Newser
Finanzdaten der Prokidney Corp-Aktie (PROK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):